The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- VRTX missed second quarter earnings by a wide margin on the top- and bottom lines. The company reported EPS of $0.46, nearly half of what … Continue Reading
Read now- Development-stage Lexicon Pharmaceuticals (NASDAQ:LXRX) served up a dish of dilution to its shareholders today, issuing 13.2MM  shares of common stock to “designees of Symphony Icon … Continue Reading
Read nowLong Ideas - Belgian drug-maker ThromboGenics NV announced last Friday that it and ex-U.S. partner Novartis (NYSE:NVS) received a nod of approval from an FDA advisory panel investigating … Continue Reading
Read now- The EU released a round of new drug approvals today, including Novartis’ (NYSE:NVS) breast-cancer treatment Afinitor which was approved by the FDA two weeks ago. … Continue Reading
Read now- The results of a Friday announcement from Pfizer (NYSE:PFE) hit the markets this morning, in which Pfizer terminated licenses to three products developed in part … Continue Reading
Read now- Auxilium Pharmaceuticals (NASDAQ:AUXL) announced top-line data from a Phase IIIb trial evaluating treatment with Xiaflex for multiple Dupuytren’s Contracture cords at one time. The company … Continue Reading
Read now- Partners Salix Pharmaceuticals (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) are trading sharply lower today as the FDA did not grant approval of their application for Relistor … Continue Reading
Read now
